Nuveen Asset Management’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $1.94M | Buy |
641,407
+167,062
| +35% | +$506K | ﹤0.01% | 2401 |
|
|
2024
Q3 | $1.75M | Buy |
474,345
+344,037
| +264% | +$1.27M | ﹤0.01% | 2486 |
|
|
2024
Q2 | $533K | Hold |
130,308
| – | – | ﹤0.01% | 2966 |
|
|
2024
Q1 | $2.05M | Hold |
130,308
| – | – | ﹤0.01% | 2389 |
|
|
2023
Q4 | $1.97M | Buy |
130,308
+2,138
| +2% | +$32.4K | ﹤0.01% | 2415 |
|
|
2023
Q3 | $2.57M | Buy |
128,170
+10,774
| +9% | +$216K | ﹤0.01% | 2195 |
|
|
2023
Q2 | $3.31M | Buy |
117,396
+2,885
| +3% | +$81.4K | ﹤0.01% | 2105 |
|
|
2023
Q1 | $1.97M | Sell |
114,511
-1,559
| -1% | -$26.8K | ﹤0.01% | 2337 |
|
|
2022
Q4 | $2.34M | Sell |
116,070
-7,496
| -6% | -$151K | ﹤0.01% | 2311 |
|
|
2022
Q3 | $2.68M | Buy |
123,566
+11,239
| +10% | +$243K | ﹤0.01% | 2243 |
|
|
2022
Q2 | $3.16M | Sell |
112,327
-5,995
| -5% | -$168K | ﹤0.01% | 2205 |
|
|
2022
Q1 | $5.79M | Sell |
118,322
-2,334
| -2% | -$114K | ﹤0.01% | 1977 |
|
|
2021
Q4 | $8.6M | Sell |
120,656
-8,383
| -6% | -$597K | ﹤0.01% | 1788 |
|
|
2021
Q3 | $9.07M | Sell |
129,039
-7,560
| -6% | -$531K | ﹤0.01% | 1845 |
|
|
2021
Q2 | $7.27M | Buy |
136,599
+19,699
| +17% | +$1.05M | ﹤0.01% | 2058 |
|
|
2021
Q1 | $5.07M | Buy |
116,900
+10,908
| +10% | +$473K | ﹤0.01% | 2166 |
|
|
2020
Q4 | $5.51M | Buy |
105,992
+65,359
| +161% | +$3.39M | ﹤0.01% | 2022 |
|
|
2020
Q3 | $1.33M | Buy |
40,633
+169
| +0.4% | +$5.53K | ﹤0.01% | 2563 |
|
|
2020
Q2 | $1.94M | Buy |
+40,464
| New | +$1.94M | ﹤0.01% | 2350 |
|